HIV-1 – Discover Pharma

Welcome to Discover Pharma! Today is : October 17, 2026

HIV-1

Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
ViiV’s Cabenuva achieves superior viral suppression in CROWN Phase 3b study
ViiV Healthcare’s long-acting HIV treatment Cabenuva achieved superior viral suppression [...]

October 6, 2026
Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
FDA approves Tivicay PD for children with HIV weighing at least 2kg
ViiV Healthcare has received US FDA approval for Tivicay PD [...]

September 4, 2026
Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas
FDA approves ViiV’s Tivicay PD for young children with HIV
The FDA has approved ViiV Healthcare’s Tivicay PD for children [...]

August 26, 2026
Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development
ViiV Healthcare HIV regimen Dovato non-inferior to Biktarvy in Phase 3b study
ViiV Healthcare’s two-drug HIV regimen Dovato was non-inferior to the [...]

July 28, 2026

main menu

recent posts

get connected

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.

OK